✦ LIBER ✦

Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes

✍ Scribed by Fonseca, V.; Falahati, A.; Zychma, M.; Madsbad, S.; Plutzky, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the once-daily hu

✍ Seino, Y.; Rasmussen, M.F.; Nishida, T.; Kaku, K. 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 599 KB

The once-daily human GLP-1 analogue lira

✍ Flint, A.; Kapitza, C.; Zdravkovic, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

Patient-reported rating of gastrointesti

✍ M. Horowitz; T. Vilsbøll; M. Zdravkovic; M. Hammer; S. Madsbad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

The once-daily human glucagon-like pepti

✍ Anne Flint; Christoph Kapitza; Charlotte Hindsberger; Milan Zdravkovic 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 238 KB

Liraglutide, a once-daily human GLP-1 an

✍ T. Vilsbøll; B. Brock; H. Perrild; K. Levin; H.-H. Lervang; K. Kølendorf; T. Kra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Effect of the once-daily human GLP-1 ana

✍ Michael Horowitz; Anne Flint; Karen L. Jones; Charlotte Hindsberger; Mads F. Ras 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 525 KB